Acne Vulgaris

Known as: Acne, Acne Vulgaris [Disease/Finding], Acne, vulgaris 
A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads… (More)
National Institutes of Health

Related topics

Related topics

50 relations
2 ML Clindamycin 150 MG/ML InjectionBenzoyl PeroxideBenzoyl Peroxide 0.1 MG/MG Topical GelBenzoyl Peroxide 100 MG/ML Topical Cream
(More)

Broader (1)

Dermatitis

Narrower (2)

Dermatitis acneiformPyogenic Arthritis, Pyoderma Gangrenosum and Acne

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013.
Importance Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Review
2012
Review
2012
Acne vulgaris
Acne is a chronic inflammatory disease of the pilosebaceous unit resulting from androgen-induced increased sebum production… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
BACKGROUND Previous, uncontrolled studies have suggested that first-line treatment with gefitinib would be efficacious in… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
BACKGROUND Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
BACKGROUND Two phase II trials in patients with previously-treated advanced non-small-cell lung cancer suggested that gefitinib… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2007
Review
2007
Guidelines of care for acne vulgaris management.
DISCLAIMER Adherence to these guidelines will not ensure successful treatment in every situation. Furthermore, these guidelines… (More)
  • table I
  • table III
  • table IV
  • table II
  • table V
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
CONTEXT More persons in the United States die from non-small cell lung cancer (NSCLC) than from breast, colorectal, and prostate… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Acne vulgaris: a disease of Western civilization.
BACKGROUND In westernized societies, acne vulgaris is a nearly universal skin disease afflicting 79% to 95% of the adolescent… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Topical ALA-photodynamic therapy for the treatment of acne vulgaris.
Topical aminolevulinic acid is converted into a potent photosensitizer, protoporphyrin, in human hair follicles and sebaceous… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris.
In this study we have evaluated the use of blue light (peak at 415 nm) and a mixed blue and red light (peaks at 415 and 660 nm… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 2
Is this relevant?